Rating History for Enanta Pharmaceuticals (ENTA) by Jefferies
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/1/2025 | Akash Tewari | Upgrade | Buy (Hold) |
20.00 (14.00) |
11.97 (13.54) |
13.12% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 10/1/2025 | Akash Tewari | Upgrade | Buy (Hold) |
20.00 (14.00) |
11.97 (13.54) |
13.12% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||